Compare Stocks

Azincourt Energy Corp., an exploration and development company, focuses on the alternative fuels/alternative energy sector in Canada and Peru. It explores for uranium and lithium deposits, as well as other clean energy elements. The company owns interest in the East Preston project covering an area of approximately 25,000 hectares located in Saskatchewan, Canada; and the Big Hill Lithium project covering approximately an area of 7,500 hectares located in southwestern Newfoundland, Canada. The company was formerly known as Azincourt Uranium Inc. and changed its name to Azincourt Energy Corp. in October 2017. Azincourt Energy Corp. was incorporated in 2011 and is headquartered in Vancouver, Canada.

GoGold Resources Inc. engages in the exploration, development, and production of gold and silver in Mexico. The company holds 100 % interest in the Parral Tailings project, which covers an area of 141 hectares located in the state of Chihuahua, Mexico. It also holds 100% interest in the Los Ricos properties, which includes Los Ricos South and Los Ricos North projects, that covers 42 concessions with an area of approximately 22,000 hectares situated in the Jalisco State, Mexico. The company was incorporated in 2008 and is headquartered in Halifax, Canada.

Virtus Convertible & Income Fund II is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Allianz Global Investors U.S. LLC. It invests in fixed income markets of the United States. The fund primarily invests in convertible securities and non-convertible high-yield bonds rated below investment grade. It invests in securities across a broad range of maturities, with the weighted average maturity ranging between five to ten years. The fund typically employs fundamental analysis with a bottom up stock picking approach to create its portfolio. It conducts in-house research using proprietary models. The fund was formerly known as AGIC Convertible & Income Fund II. Virtus Convertible & Income Fund II was formed on July 31, 2003 and is domiciled in the United States.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.